scispace - formally typeset
K

Kristina Secnik

Researcher at Eli Lilly and Company

Publications -  36
Citations -  9268

Kristina Secnik is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Type 2 diabetes. The author has an hindex of 21, co-authored 36 publications receiving 8444 citations. Previous affiliations of Kristina Secnik include Harvard University.

Papers
More filters
Journal ArticleDOI

The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder

TL;DR: The findings suggest that HRQL instruments can add important information to efficacy measures in clinical trials of ADHD treatment, and the Child Health Questionnaire 50-item Parent Form scales assessing psychosocial domains of HRQL were significantly negatively correlated with clinical measures.
Journal ArticleDOI

Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain.

TL;DR: Overall, the search showed costs are well documented in Australia, Canada, France and Germany, but revealed a paucity of data for Spain and Italy, and there may be a need for future economic evaluations measuring the accuracy of the costs and resource utilization in the reported values.
Journal ArticleDOI

Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes.

TL;DR: Results of this analysis suggest that managed care members with type 2 diabetes who stayed continuously at the target A1c level of 7% or less over a 1-year follow-up period incurred lower diabetes-related costs compared with managed careMembers with type 1 diabetes who were continuously over thetarget A1C level.
Journal ArticleDOI

Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder.

TL;DR: Study results indicate the CHQ-PF50 is reliable, valid, and responsive to change in ADHD symptoms, suggesting it may provide a means of assessing HRQL outcomes associated with treatments for ADHD.
Journal ArticleDOI

Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.

TL;DR: Analysis of patterns of antidiabetic treatment among individuals with type 2 diabetes in Germany and investigated potential differences in attainment of glycemic control associated with the use of specific antidi diabetic regimens found patients who were prescribed insulin monotherapy or combination therapy were least likely to achieve the HbA(1c) target.